Remifemin by Ray Sahelian

Remifemin by Ray Sahelian, M.D. Health benefit of Remifenin supplement for menopause

Remifemin is a black cohosh product marketed in the US by Enzymatic therapy.

Enzymatic Therapy Remifemin, Non-Prescription Menopausal Therapy, 120 Tablets
Proven Safe
Estrogen free
Delivers relief of Hot Flashes, Night Sweats, Mood Swings
Dietary Supplement
With RemiSure Black Cohosh

Unique-Exclusive, standardized extract, subject of over 90 scientific papers.
Safe-Completely hormone-free without plant-based estrogens that can affect breast and uterine cell growth. Can be used safely by woman with a history of breast cancer who cannot take estrogen.
Recent clinical study show 70% reduction in hot flashes, night sweats, mood swings, irritability, and related occasional sleeplessness.

Remifemin Supplement Facts:
Serving Size: 1 Tablet
Servings Per Container: 120 Tablet
Amount Per Serving % Daily Value
Black Cohosh Extract (Root and Rhizome) Equivalent to 20 mg **
* Percent Daily Values not established.

Other Ingredients: Lactose (milk), cellulose, potato starch, magnesium stearate, and natural peppermint flavor.
Standardized to be equivalent to 20 mg Black Cohosh (Cimicifuga racemosa) root and rhizome.

Suggested Use: One Tablet in the morning and one tablet in the evening, with water. You can expect to notice improvements within a few weeks, with full benefits after using Remifemin twice daily for 4-12 weeks.

Remifemin for menopause symptoms
Although many studies show Remifemin to have benefits, controversy continues as to whether Remifemin is effective for menopausal symptoms. For more information on natural ways to treat menopause.

Not All Black Cohosh Is the Same - press release by Enzymatic Therapy, Inc.
GREEN BAY, Wis., Dec 20, 2006 /PRNewswire via COMTEX/ -- Over 90 research papers, 15 published studies and 50 years of usage by women worldwide show that Remifemin black cohosh is effective for alleviating menopausal symptoms including hot flashes, night sweats and occasional mood swings. Although research just published in the Annals of Internal Medicine (Dec 19, 2006;145:869-879) concluded that the type of black cohosh used in this study is ineffective for treating menopause-related symptoms, the study did not use the proprietary Remifemin black cohosh.
"Not all black cohosh is the same," said Dr. Eckehard Liske, Director of the International Medical Department, Shaper & Brummer GmbH, Salzgitter, Germany. "Remifemin is produced using a proprietary isopropanolic extraction method which yields a more complete spectrum of active compounds than other extraction methods. The body of published research on Remifemin demonstrates consistent positive results, unlike other black cohosh extracts." "Multiple randomized controlled trials clearly show the benefits of Remifemin in relieving the symptoms of menopause," explained Dr. Liske. "The most recent study by Osmers (2005) found a statistically relevant effect of Remifemin in relieving menopausal symptoms including hot flashes. This study was reviewed by the North American Menopause Society and given the highest level of validation. Remifemin is a safe and effective intervention for the relief of hot flashes and other vasomotor symptoms associated with menopause." Remifemin comprises a proprietary, standardized extract (uniform dosage) of pure black cohosh root called RemiSure. It is the most OB/GYN-recommended non-prescription menopausal therapy. The German E Commission has approved the use of 40 mg/day of black cohosh (Remifemin brand) for 6 months for relief of menopausal symptoms, as well as for premenstrual syndrome (PMS) and dysmenorrhea. "Remifemin is clearly the world's most clinically tested black cohosh product," said Mark Blumenthal, Founder and Executive Director of the American Botanical Council. "At least 15 clinical trials demonstrate the safety and efficacy of the product, manufactured according to the latest GMPs by Shaper & Brummer GmbH, a highly respected German phytomedicine company with over 50 years of experience in manufacturing and testing Remifemin. Most of the scientific literature on black cohosh was conducted on Remifemin including recent clinical trials showing no estrogenic activity of the product," he explained. "Smart German chemists have been working on Remifemin for over 50 years," said Yale University School of Medicine Clinical Professor Mary Jane Minkin, MD, who recommends Remifemin as a standard alternative to HRT. "Remifemin black cohosh is one of the few products that I recommend by name. I talk to everyone about Remifemin along with lifestyle issues like healthy diet and exercise," she explained. "I respect the personal preferences of my patients, many of whom do not want drug intervention." Dr. Minkin is author of A Woman's Guide to Menopause & Perimenopause (Yale University Press 2005).
Remifemin was first introduced to the U.S. market in 1995 by Enzymatic Therapy, Inc., the exclusive distributors of the product in North America, and first to introduce standardization to the U.S. supplement industry.